No Data
Iterum Therapeutics Notified Pfizer, Electing To Defer Milestone Payment For 2 Years For ORLYNVAH, Or Until Oct 25, 2026
UBS Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $31
Pfizer Options Spot-On: On November 1st, 168.83K Contracts Were Traded, With 3.16 Million Open Interest
On November 1st ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 168.83K options for the day, of which put options accounted for 36.34% of the total transactions, and
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
Eli Lilly's Zepbound Sales, Pfizer Wants in on Weight Loss Drugs, AbbVie's Big Deal: Pharma News Round up
Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?